www.metherapeutics.com
Open in
urlscan Pro
74.121.34.60
Public Scan
Submitted URL: https://metherapeutics.com/
Effective URL: https://www.metherapeutics.com/
Submission: On December 07 via api from US — Scanned from CA
Effective URL: https://www.metherapeutics.com/
Submission: On December 07 via api from US — Scanned from CA
Form analysis 2 forms found in the DOM
Name: New Form — POST
<form class="elementor-form" method="post" name="New Form">
<input type="hidden" name="post_id" value="30038">
<input type="hidden" name="form_id" value="59f6099">
<input type="hidden" name="referer_title" value="Home - ME Therapeutics Inc."><input type="hidden" name="queried_id" value="30038">
<div class="elementor-form-fields-wrapper elementor-labels-">
<div class="elementor-field-type-text elementor-field-group elementor-column elementor-field-group-name elementor-col-50">
<label for="form-field-name" class="elementor-field-label elementor-screen-only"> First Name </label>
<input size="1" type="text" name="form_fields[name]" id="form-field-name" class="elementor-field elementor-size-sm elementor-field-textual" placeholder="First Name">
</div>
<div class="elementor-field-type-text elementor-field-group elementor-column elementor-field-group-field_061f1ea elementor-col-50">
<label for="form-field-field_061f1ea" class="elementor-field-label elementor-screen-only"> firstname </label>
<input size="1" type="text" name="form_fields[field_061f1ea]" id="form-field-field_061f1ea" class="elementor-field elementor-size-sm elementor-field-textual" placeholder="Last Name">
</div>
<div class="elementor-field-type-email elementor-field-group elementor-column elementor-field-group-email elementor-col-100 elementor-field-required">
<label for="form-field-email" class="elementor-field-label elementor-screen-only"> Email </label>
<input size="1" type="email" name="form_fields[email]" id="form-field-email" class="elementor-field elementor-size-sm elementor-field-textual" placeholder="Email" required="required" aria-required="true">
</div>
<div class="elementor-field-group elementor-column elementor-field-type-submit elementor-col-100 e-form__buttons">
<button class="elementor-button elementor-size-md" type="submit">
<span class="elementor-button-content-wrapper">
<span class="elementor-button-text">JOIN</span>
</span>
</button>
</div>
</div>
</form>Name: New Form — POST
<form class="elementor-form" method="post" name="New Form">
<input type="hidden" name="post_id" value="30218">
<input type="hidden" name="form_id" value="d972c4e">
<input type="hidden" name="referer_title" value="Home - ME Therapeutics Inc."><input type="hidden" name="queried_id" value="30038">
<div class="elementor-form-fields-wrapper elementor-labels-">
<div class="elementor-field-type-text elementor-field-group elementor-column elementor-field-group-name elementor-col-50">
<label for="form-field-name" class="elementor-field-label elementor-screen-only"> Name </label>
<input size="1" type="text" name="form_fields[name]" id="form-field-name" class="elementor-field elementor-size-sm elementor-field-textual" placeholder="First Name">
</div>
<div class="elementor-field-type-text elementor-field-group elementor-column elementor-field-group-field_3f88d7f elementor-col-50">
<label for="form-field-field_3f88d7f" class="elementor-field-label elementor-screen-only"> Name </label>
<input size="1" type="text" name="form_fields[field_3f88d7f]" id="form-field-field_3f88d7f" class="elementor-field elementor-size-sm elementor-field-textual" placeholder="Last Name">
</div>
<div class="elementor-field-type-email elementor-field-group elementor-column elementor-field-group-email elementor-col-100 elementor-field-required">
<label for="form-field-email" class="elementor-field-label elementor-screen-only"> Email </label>
<input size="1" type="email" name="form_fields[email]" id="form-field-email" class="elementor-field elementor-size-sm elementor-field-textual" placeholder="Email Address" required="required" aria-required="true">
</div>
<div class="elementor-field-type-textarea elementor-field-group elementor-column elementor-field-group-message elementor-col-100">
<label for="form-field-message" class="elementor-field-label elementor-screen-only"> Message </label><textarea class="elementor-field-textual elementor-field elementor-size-sm" name="form_fields[message]" id="form-field-message" rows="4"
placeholder="Write your message here"></textarea>
</div>
<div class="elementor-field-group elementor-column elementor-field-type-submit elementor-col-30 e-form__buttons">
<button class="elementor-button elementor-size-md" type="submit">
<span class="elementor-button-content-wrapper">
<span class="elementor-button-text">SEND</span>
</span>
</button>
</div>
</div>
</form>Text Content
Skip to content * Home * About Us * Science * Investors * News * AGM Material Menu * Home * About Us * Science * Investors * News * AGM Material Contact Us * Home * About Us * Science * Investors * News * AGM Material Menu * Home * About Us * Science * Investors * News * AGM Material Contact Us * Home * About Us * Science * Investors * News * AGM Material Menu * Home * About Us * Science * Investors * News * AGM Material Contact Us DEVELOPING NEXT GENERATION THERAPEUTICS TARGETING IMMUNE SUPPRESSION IN CANCER. WHO WE ARE Our team has a proven track record with immunology expertise in cancer and inflammation. MEET OUR TEAM WHAT WE DO We are developing novel drugs targeting a class of immune cells called myeloid cells to directly treat cancer as well as to enhance the benefits of current Immuno Oncology drugs such as checkpoint inhibitors in currently untreatable cancers. LEARN MORE THE SCIENCE Immuno Oncology (IO) is a new area of cancer research which has been successful in treating previously untreatable cancers. IO targets the immune system rather than the cancer directly which potentially allows a single IO drug to be used to treat multiple cancer types with mostly manageable side effects. READ MORE NEWSROOM Our latest company news and scientific findings. BC, VANCOUVER | 07/18/2024 ME THERAPEUTICS ANNOUNCES NEW COLLABORATION WITH NANOVATION THERAPEUTICS ON ADVANCED THERAPEUTIC MRNA DELIVERY TO MYELOID CELLS ME Therapeutics Holdings Inc. (METX:CSE), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of.... BC, VANCOUVER | 05/29/2024 ME THERAPEUTICS HOLDINGS INC. ANNOUNCES THE ADDITION OF TWO NEW CLINICAL CONSULTANTS TO CONTINUE THE ADVANCEMENT OF OUR LEAD ANTI-G-CSF ANTIBODY CANDIDATE TOWARDS A FIRST-IN-HUMAN CLINICAL TRIAL ME Therapeutics Holdings Inc. (METX:CSE), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of.... BC, VANCOUVER | 05/17/2024 ME THERAPEUTICS TO PRESENT AT INVESTOR CLUBHOUSE AT THE CANADIAN OPEN AND ATTEND THE 2024 BIO INTERNATIONAL CONVENTION FOR PARTNERING OPPORTUNITIES ME Therapeutics Holdings Inc. (METX:CSE), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of.... BC, VANCOUVER | 10/28/2024 ME THERAPEUTICS HOLDINGS INC. APPOINTS CHIEF BUSINESS OFFICER ME Therapeutics Holdings Inc. (METX:CSE), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of.... BC, VANCOUVER | 10/23/2024 ME THERAPEUTICS HOLDINGS INC. PROVIDES RESEARCH AND DEVELOPMENT UPDATE AND CORPORATE UPDATE ME Therapeutics Holdings Inc. (METX:CSE), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of.... BC, VANCOUVER | 09/18/2024 ME THERAPEUTICS ANNOUNCES THE START OF TESTING OF FIRST MRNA FORMULATIONS FROM NANOVATION THERAPEUTICS COLLABORATION ME Therapeutics Holdings Inc. (METX:CSE), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of.... BC, VANCOUVER | 07/18/2024 ME THERAPEUTICS ANNOUNCES NEW COLLABORATION WITH NANOVATION THERAPEUTICS ON ADVANCED THERAPEUTIC MRNA DELIVERY TO MYELOID CELLS ME Therapeutics Holdings Inc. (METX:CSE), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of.... BC, VANCOUVER | 05/29/2024 ME THERAPEUTICS HOLDINGS INC. ANNOUNCES THE ADDITION OF TWO NEW CLINICAL CONSULTANTS TO CONTINUE THE ADVANCEMENT OF OUR LEAD ANTI-G-CSF ANTIBODY CANDIDATE TOWARDS A FIRST-IN-HUMAN CLINICAL TRIAL ME Therapeutics Holdings Inc. (METX:CSE), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of.... BC, VANCOUVER | 05/17/2024 ME THERAPEUTICS TO PRESENT AT INVESTOR CLUBHOUSE AT THE CANADIAN OPEN AND ATTEND THE 2024 BIO INTERNATIONAL CONVENTION FOR PARTNERING OPPORTUNITIES ME Therapeutics Holdings Inc. (METX:CSE), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of.... BC, VANCOUVER | 10/28/2024 ME THERAPEUTICS HOLDINGS INC. APPOINTS CHIEF BUSINESS OFFICER ME Therapeutics Holdings Inc. (METX:CSE), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of.... BC, VANCOUVER | 10/23/2024 ME THERAPEUTICS HOLDINGS INC. PROVIDES RESEARCH AND DEVELOPMENT UPDATE AND CORPORATE UPDATE ME Therapeutics Holdings Inc. (METX:CSE), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of.... BC, VANCOUVER | 09/18/2024 ME THERAPEUTICS ANNOUNCES THE START OF TESTING OF FIRST MRNA FORMULATIONS FROM NANOVATION THERAPEUTICS COLLABORATION ME Therapeutics Holdings Inc. (METX:CSE), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of.... View All KEEP UP TO DATE BY SUBSCRIBING TO OUR MAILING LIST First Name firstname Email JOIN LINKS * Home * About * Science * Latest Research * Investors * News * Disclaimer SOCIAL GET IN TOUCH ME Therapeutics 177 Robson St. Vancouver, BC,Canada V6B 0N3 Name Name Email Message SEND © 2023 ME THERAPEUTICS ALL RIGHTS RESERVED. METX (CSE) Q9T (FSE)